Terms: = Head and neck cancer AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1
324 results:
1. Comparison of mutation landscapes of pretreatment versus recurrent squamous cell carcinoma of the oral cavity: The possible mechanism of resistance to standard treatment.
Payungwong T; Angkulkrerkkrai K; Chaiboonchoe A; Lausoontornsiri W; Jirawatnotai S; Chindavijak S
Cancer Rep (Hoboken); 2024 Mar; 7(3):e2004. PubMed ID: 38477073
[TBL] [Abstract] [Full Text] [Related]
2. ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia.
Lin TY; Jia JS; Luo WR; Lin XL; Xiao SJ; Yang J; Xia JW; Zhou C; Zhou ZH; Lin SJ; Li QW; Yang ZZ; Lei Y; Yang WQ; Shen HF; Huang SH; Wang SC; Chen LB; Yang YL; Xue SW; Li YL; Dai GQ; Zhou Y; Li YC; Wei F; Rong XX; Luo XJ; Zhao BX; Huang WH; Xiao D; Sun Y
J Exp Clin Cancer Res; 2024 Feb; 43(1):62. PubMed ID: 38419081
[TBL] [Abstract] [Full Text] [Related]
3. Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial.
Besse B; Pons-Tostivint E; Park K; Hartl S; Forde PM; Hochmair MJ; Awad MM; Thomas M; Goss G; Wheatley-Price P; Shepherd FA; Florescu M; Cheema P; Chu QSC; Kim SW; Morgensztern D; Johnson ML; Cousin S; Kim DW; Moskovitz MT; Vicente D; Aronson B; Hobson R; Ambrose HJ; Khosla S; Reddy A; Russell DL; Keddar MR; Conway JP; Barrett JC; Dean E; Kumar R; Dressman M; Jewsbury PJ; Iyer S; Barry ST; Cosaert J; Heymach JV
Nat Med; 2024 Mar; 30(3):716-729. PubMed ID: 38351187
[TBL] [Abstract] [Full Text] [Related]
4. Esophageal cancer in octogenarians: Should esophagectomy be done?
Cooper L; Orgad R; Levi Y; Shmilovitch H; Feferman Y; Solomon D; Kashtan H
J Geriatr Oncol; 2024 Mar; 15(2):101710. PubMed ID: 38281389
[TBL] [Abstract] [Full Text] [Related]
5. The Interaction between CLSPN Gene Polymorphisms and Alcohol Consumption Contributes to Oral cancer Progression.
Hsieh MJ; Lo YS; Ho HY; Lin CC; Chuang YC; Chen MK
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256171
[TBL] [Abstract] [Full Text] [Related]
6. Impact of intraoperative fluid management on postoperative complications in patients undergoing minimally invasive esophagectomy for esophageal cancer: a retrospective single-center study.
Takahashi M; Toyama H; Takahashi K; Kaiho Y; Ejima Y; Yamauchi M
BMC Anesthesiol; 2024 Jan; 24(1):29. PubMed ID: 38238681
[TBL] [Abstract] [Full Text] [Related]
7. Implementing the time-to-event continual reassessment method in the presence of partial orders in a phase I head and neck cancer trial.
Patel A; Brock K; Slade D; Gaunt C; Kong A; Mehanna H; Billingham L; Gaunt P
BMC Med Res Methodol; 2024 Jan; 24(1):11. PubMed ID: 38218799
[TBL] [Abstract] [Full Text] [Related]
8. Semilicoisoflavone B induces oral cancer cell apoptosis by targeting claspin and atr-Chk1 signaling pathways.
Hsieh MJ; Lin CC; Lo YS; Chuang YC; Ho HY; Chen MK
Environ Toxicol; 2024 Apr; 39(4):2417-2428. PubMed ID: 38197544
[TBL] [Abstract] [Full Text] [Related]
9. A Video-Based Procedure-Specific Competency Assessment Tool for Minimally Invasive Esophagectomy.
Ketel MHM; Klarenbeek BR; Eddahchouri Y; Cheong E; Cuesta MA; van Daele E; Ferri LE; Gisbertz SS; Gutschow CA; Hubka M; Hölscher AH; Law S; Luyer MDP; Merritt RE; Morse CR; Mueller CL; Nieuwenhuijzen GAP; Nilsson M; Pattyn P; Shen Y; van den Wildenberg FJH; Abma IL; Rosman C; van Workum F
JAMA Surg; 2024 Mar; 159(3):297-305. PubMed ID: 38150247
[TBL] [Abstract] [Full Text] [Related]
10. CHARIOT: a phase I study of berzosertib with chemoradiotherapy in oesophageal and other solid cancers using time to event continual reassessment method.
Javed SR; Lord S; El Badri S; Harman R; Holmes J; Kamzi F; Maughan T; McIntosh D; Mukherjee S; Ooms A; Radhakrishna G; Shaw P; Hawkins MA
Br J Cancer; 2024 Feb; 130(3):467-475. PubMed ID: 38129525
[TBL] [Abstract] [Full Text] [Related]
11. Preclinical Evaluation of the atr Inhibitor BAY 1895344 as a Radiosensitizer for head and neck Squamous Cell Carcinoma.
Odhiambo DA; Pittman AN; Rickard AG; Castillo RJ; Bassil AM; Chen J; Ravotti ML; Xu ES; Himes JE; Daniel AR; Watts TL; Williams NT; Luo L; Kirsch DG; Mowery YM
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1315-1327. PubMed ID: 38104870
[TBL] [Abstract] [Full Text] [Related]
12. RASSF1A promotes ATM signaling and
Gao A; Bai P; Zhang M; Yao Y; Herman JG; Guo M
Epigenomics; 2023 Nov; 15(22):1205-1220. PubMed ID: 38093706
[No Abstract] [Full Text] [Related]
13. Propofol inhibits the proliferation, invasion, migration, and angiogenesis of oral squamous cell carcinoma through circ_0008898-mediated pathway.
Dong H; Zhou W; Han L; Zhao Q
Chem Biol Drug Des; 2024 Jan; 103(1):e14393. PubMed ID: 37955304
[TBL] [Abstract] [Full Text] [Related]
14. The atr inhibitor berzosertib acts as a radio- and chemosensitizer in head and neck squamous cell carcinoma cell lines.
Schnoell J; Sparr C; Al-Gboore S; Haas M; Brkic FF; Kadletz-Wanke L; Heiduschka G; Jank BJ
Invest New Drugs; 2023 Dec; 41(6):842-850. PubMed ID: 37934325
[TBL] [Abstract] [Full Text] [Related]
15. Identification and validation of novel prognostic signatures based on m5C methylation patterns and tumor EMT profiles in head and neck squamous cell carcinoma.
Zhu G; Wang W; Yao H; Li H; Zhang C; Meng Y; Wang J; Zhu M; Zheng H
Sci Rep; 2023 Oct; 13(1):18763. PubMed ID: 37907576
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic inhibition of atr in differentiated thyroid cancer.
Lin SF; Lee YY; Wu MH; Lu YL; Yeh CN; Chen WY; Chou TC; Wong RJ
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37902083
[TBL] [Abstract] [Full Text] [Related]
17. Nutritional status and its correlation to prognosis of nasopharyngeal carcinoma patients in different ages in China: a multicenter cohort study.
Jia P; Wu X; Shen F; Xu G; Xu H; Cong M; Song C; Shi H
Support Care Cancer; 2023 Oct; 31(12):638. PubMed ID: 37847417
[TBL] [Abstract] [Full Text] [Related]
18. The cGAS/STING/IFN-1 Response in Squamous head and neck cancer Cells after Genotoxic Challenges and Abrogation of the atr-Chk1 and Fanconi Anemia Axis.
Zahnreich S; El Guerzyfy S; Kaufmann J; Schmidberger H
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834346
[TBL] [Abstract] [Full Text] [Related]
19. Risk and prevalence of oral cancer in patients with different types of lupus erythematosus: a systematic review and meta-analysis.
Rodrigues LRS; Ferraz DLF; de Oliveira CRG; Evangelista K; Silva MAG; Silva FPY; Silva BSF
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Nov; 136(5):595-605. PubMed ID: 37635011
[TBL] [Abstract] [Full Text] [Related]
20. TPP1 Inhibits DNA Damage Response and Chemosensitivity in Esophageal cancer.
Wen J; Zhong X; Gao C; Yang M; Tang M; Yuan Z; Wang Q; Xu L; Ma Q; Guo X; Fang L
Crit Rev Eukaryot Gene Expr; 2023; 33(8):77-91. PubMed ID: 37606165
[TBL] [Abstract] [Full Text] [Related]
[Next]
